Alissa Lipton’s practice involves representing biotechnology and pharmaceutical companies in patent proceedings in district courts, before the U.S. Court of Appeals for the Federal Circuit, and before the U.S. Patent and Trademark Office (USPTO). Her practice also involves strategic client counseling, including due diligence and opinion work, and portfolio management.

Alissa has over a decade of experience representing companies in patent litigation, from pre-litigation analysis through appeal to the Federal Circuit. She also provides strategic counsel to clients in technologies including therapeutic antibodies, CRISPR, antisense technologies, diagnostics, and small molecules. Alissa’s practice includes due diligence, freedom-to-operate, enforceability, and infringement assessments.